Hepatocellular Carcinoma in Hemochromatosis: Where or When?

This publication has 7 references indexed in Scilit:

• Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes
  Digestive Diseases and Sciences, 2022
• Survival and development of health conditions after iron depletion therapy in C282Y-linked hemochromatosis patients
  Canadian Liver Journal, 2021
• Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy
  JAMA, 2020
• Clinical Penetrance of Hereditary Hemochromatosis-Related End-Organ Damage of C282Y Homozygosity, A Newfoundland Experience
  Clinical and Translational Gastroenterology, 2020
• Reduced phenotypic expression in genetic hemochromatosis with time: Role of exposure to non-genetic modifiers
  Journal of Hepatology, 2019
• Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population
  New England Journal of Medicine, 2005
• Survival and Causes of Death in Hemochromatosis
  Annals of the New York Academy of Sciences, 1988